PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 225 filers reported holding PHARMACYCLICS INC in Q3 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,792,000 | +485.6% | 7,000 | +180.0% | 1.20% | +624.8% |
| Q4 2014 | $306,000 | -47.9% | 2,500 | -50.0% | 0.16% | -60.2% |
| Q3 2014 | $587,000 | +162.1% | 5,000 | +100.0% | 0.42% | +198.6% |
| Q2 2014 | $224,000 | -15.2% | 2,500 | 0.0% | 0.14% | +9.4% |
| Q4 2013 | $264,000 | -91.3% | 2,500 | -88.6% | 0.13% | -93.2% |
| Q3 2013 | $3,042,000 | +155.2% | 22,000 | +46.7% | 1.86% | +119.2% |
| Q2 2013 | $1,192,000 | – | 15,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |